Latest News

Trying to decide whether to buy, hold, or sell Santen Pharmaceutical? You are definitely not alone. The stock has attracted attention thanks to some eye-catching moves: a modest 0.3% bump last week, 2.8% up over the last month, and a respectable 1.0% gain since the start of the year. What also stands out is the rollercoaster of recent years. While Santen’s share price soared an impressive 77.9% over the last three years, it is still trailing its five-year mark by 13.6%. Clearly, perceptions...

Struggling with what to do about Regency Centers stock? You are not alone. With shares last closing at $71.34 and the stock logging a return of -2.4% in the past week, investors are watching closely for signs of which way things might move next. While the near-term numbers may feel a touch underwhelming, take a step back and the story gets much more interesting. Over the past five years, Regency Centers has surged 134.7%. Even the past three years have delivered a solid total gain of 36.9%...

Wondering what to do with Evolent Health stock after a wild ride in the market? You are not alone. The stock has turned heads in both directions lately, with a 6.7% dip over the past week and a 3% slip over the past month. If you have held on through the past year, it has been especially challenging, given a staggering 70.3% drop over that period. Even the longer-term returns, down 76.4% for three years and 21.6% over five years, may have shaken the confidence of even the most steadfast...

If you are on the fence about what to do with China Telecom stock right now, you are not alone. Plenty of investors are watching this company closely after a run that has seen the share price deliver a stellar 229.7% gain over the past five years. Even after a flat week and a modest pullback of 9.3% over the past month, the long-term trend is very much intact, with 143.0% returns in three years and an eye-catching 39.6% gain in just the last year. Year-to-date, shares are up 21.9%, easily...

If you are weighing your options with Indivior, you are not alone in wondering whether now is the right time to get on board, hold steady, or lock in some gains. Indivior has made plenty of headlines with its impressive long-term performance. The stock has soared 143.3% over the past year and a staggering 211.5% over five years, turning patient investors into clear winners. Even so, the past month shows a mild pullback of -1.1%, and the last week has seen a sharper dip of -6.2%. These recent...

If you are weighing your next move on Tingyi (Cayman Islands) Holding, you are definitely not alone. With so many updates and shifts in the broader consumer staples sector, plenty of investors are revisiting this stock to decide if now is the right time to buy, sell, or simply hold on. Let us look at what has been happening: after a solid rise of 18.0% over the past five years, Tingyi's stock has climbed 12.2% year-to-date and 12.7% over the last year. The past month was a little quieter with...

Key Insights Veralto's estimated fair value is US$135 based on 2 Stage Free Cash Flow to Equity Veralto's US$109 share...

With the business potentially at an important milestone, we thought we'd take a closer look at Orion Energy Systems...

Big Tree Cloud Holdings (NasdaqGM:DSY) has suddenly captured attention after a massive jump in its stock value last week, with shares rising 172%. What has everyone talking is not just the rally itself, but the fact that insiders, especially CEO Wenquan Zhu, who owns a striking 88% of the company, have been the primary beneficiaries of this move. Minimal institutional involvement and scant analyst coverage mean this surge feels very much driven by those closest to the business, rather than...

If you’ve been tracking Service Stream (ASX:SSM), the $1.6 billion base services contract it just landed with the Australian Department of Defence is big news. This agreement covers 113 sites and training facilities over an initial six-year term and positions Service Stream to broaden its reach well beyond its traditional markets. For investors, this win clearly signals a major shift as the company moves further into the defence sector and secures stable, government-backed revenue streams for...

Key Insights Insiders appear to have a vested interest in 2G Energy's growth, as seen by their sizeable ownership The...

If you have been watching Mineralys Therapeutics lately, you are probably wondering just how much more it can deliver for your portfolio. The buzz is real, and so are the numbers. With a 155.5% surge over the past 30 days and a staggering 202.9% gain so far this year, Mineralys has certainly gotten investors’ attention. Its one-year return of 219.8% stands out not just in its sector, but across the broader market as well. Part of this momentum can be traced to growing optimism around...

We wouldn't blame Lazard, Inc. ( NYSE:LAZ ) shareholders if they were a little worried about the fact that Evan Russo...

Enghouse Systems Limited reported third quarter 2025 results in early September, announcing declines in year-over-year revenue and net income, the completion of its Trafi acquisition integration, and an affirmed quarterly dividend of CA$0.30 per share payable in November. Company leadership highlighted their continued pursuit of acquisitions with a disciplined approach, supported by a leaner cost structure and a strong cash position. We'll now examine how Enghouse's reaffirmed acquisition...

Quálitas Controladora, S.A.B. de C.V. ( BMV:Q ) shareholders might be concerned after seeing the share price drop 14...

RLX Technology's (NYSE:RLX) stock is up by a considerable 23% over the past month. However, we decided to pay attention...

With a price-to-earnings (or "P/E") ratio of 16.7x Abbott Laboratories ( NYSE:ABT ) may be sending bullish signals at...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Haemonetics fair value estimate is US$100 Haemonetics...

Apex Investment PSC's (ADX:APEX) stock is up by 6.9% over the past three months. We wonder if and what role the...

This week we saw the Solutions 30 SE ( EPA:S30 ) share price climb by 13%. But will that heal all the wounds inflicted...

As the U.S. stock market navigates a landscape of mixed signals, with the Nasdaq reaching new heights while inflation data and interest rate expectations loom large, small-cap stocks are attracting attention for their potential resilience and growth opportunities. In such a climate, identifying promising small-cap companies involves looking at factors like insider buying trends and regional diversification, which can offer valuable insights into a company's perceived value and future prospects.

As the U.S. stock market navigates a landscape marked by mixed index performances and anticipation of interest rate decisions, investors are keenly observing sectors that could benefit from potential economic shifts. In this environment, identifying stocks trading below their intrinsic value can offer opportunities for those looking to capitalize on underappreciated assets, particularly as market conditions evolve.

As of September 2025, the U.S. stock market is experiencing a mixed performance with the Nasdaq Composite reaching new record highs, driven by strong gains in tech stocks like Tesla and Microsoft. Amid this backdrop, investors are keenly watching for potential Federal Reserve interest rate cuts that could further influence market dynamics. In such an environment, growth companies with high insider ownership can offer unique insights into confidence levels within their leadership teams and may...

As the U.S. market navigates a landscape marked by mixed performances in major indices and anticipation of interest rate cuts from the Federal Reserve, small-cap stocks present intriguing opportunities for investors looking beyond the headline-grabbing tech giants. In this environment, identifying stocks with solid foundations—such as strong financial health, innovative products, or robust growth potential—can be key to uncovering hidden gems like NetScout Systems and other promising...